Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: The DANSUK study

European Journal of Preventive Cardiology

Volumn 13, Issue 5, 2006, Pages 784-790

  Soja, Anne Merete Boas ^a   Zwisler, Ann Dorthe Olsen ^b   Melchior, Thomas ^c   Hommel, Eva ^d   Torp Pedersen, Christian ^a   Madsen, Mette ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c ROSKILDE HOSPITAL   (Denmark)

^d STENO DIABETES CENTER   (Denmark)

Author keywords

cardiac rehabilitation; impaired fasting glucose; impaired glucose tolerance; oral glucose tolerance test; type 2 diabetes

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FEMALE; GLUCOSE BLOOD LEVEL; HEART REHABILITATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATIENT REFERRAL; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE; SCREENING TEST; WORLD HEALTH ORGANIZATION;

AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 33749014387     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000238391.12223.d0     Document Type: Article

References (23)

1. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–853.
2. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383–393.
3. Norhammar A, Tenerz AA, Nilsson G, Hamsten A, Efendic S, Rydén L, et al Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140–2144.
4. Taubert G, Winkelmann R, Schleiffer T, Marz W, Winkler R, Gok R, et al Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 2003; 145: 285–291.
5. Lear SA, Ignaszewski A, Linden W, Brozic A, Kiess M, Spinelli JJ, et al A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data. Curr Control Trials Cardiovasc Med 2002; 3: 9–23.
6. Bartnik M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, et al Euro Heart Survey Investigators. The prevalence of abnormal glucose regulation in the patients with coronary artery disease across Europe. The Euro heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880–1890.
7. Zwisler AD, Schou L, Soja AMB, Broennum-Hansen H, Gluud C, Iversen L, et al A randomized clinical trial of hospitalbased, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease or high-risk of ischemic heart disease (the DANREHAB Trial) – design, intervention and population. Am Heart J 2005; 150: 899.e7–8999.e16.
8. Ellis G, Diamandis EP, Giesbrechts EE, Daneman D, Allen LC. An automated high pressure liquid-chromatographic assay for hemoglobin A1c. Clin Chem 1984; 30: 1746–1752.
9. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
10. American Diabetes Association. Clinical practice recommendations 2005. Diabetes Care 2005; 28 (Suppl. 1):S1–S79.
11. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364–376.
12. Lau C, Fćrch K, Glümer C, Tetens I, Pedersen O, Carstensen B, et al Inter99 Study. Dietary glycemic index, glycemic load, fiber, simple sugars, and insulin resistance – the Inter99 study. Diabetes Care 2005; 28: 1397–1403.
13. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 36: 959–969.
14. Remme WJ, Swedberg K. Task force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guideline for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527–1560.
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–1197.
16. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovas-cular disease in older women and men: the Rancho Bernardo Study. Diabetes Care 1998; 21: 1236–1239.
17. The DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Consequences of the new diagnostic criteria for diabetes in older men and women. Diabetes Care 1999; 22: 1667–1671.
18. The DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003; 26: 688–696.
19. The DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998; 317: 371–375.
20. Borch-Johnsen K, Colagiuri S, Balkau B, Glümer C, Carstensen B, Ramachandran A, et al Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 2004; 47: 1396–1402.
21. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al Diabetes Prevention Programme Research Group. Reduction in the incidense of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.
22. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111: 754–760.
23. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in life style among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–1350.